Cynthia Nustad Net Worth

The estimated Net Worth of Cynthia Nustad is at least $5.98 Million dollars as of 3 December 2018. Cynthia Nustad owns over 73,781 units of HMS Corp stock worth over $2,593,815 and over the last 14 years Cynthia sold HMSY stock worth over $3,385,670.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Cynthia Nustad HMSY stock SEC Form 4 insiders trading

Cynthia has made over 9 trades of the HMS Corp stock since 2013, according to the Form 4 filled with the SEC. Most recently Cynthia sold 73,781 units of HMSY stock worth $2,575,695 on 3 December 2018.

The largest trade Cynthia's ever made was exercising 112,397 units of HMS Corp stock on 28 November 2018 worth over $1,436,434. On average, Cynthia trades about 10,801 units every 53 days since 2011. As of 3 December 2018 Cynthia still owns at least 70,160 units of HMS Corp stock.

You can see the complete history of Cynthia Nustad stock trades at the bottom of the page.

What's Cynthia Nustad's mailing address?

Cynthia's mailing address filed with the SEC is 401 PARK AVENUE SOUTH, , NEW YORK, NY, 10016.

Insiders trading at HMS Corp

Over the last 22 years, insiders at HMS Corp have traded over $52,929,119 worth of HMS Corp stock and bought 86,410 units worth $1,190,400 . The most active insiders traders include William C Lucia, Daniel Newman Mendelson, and Iii William F Miller. On average, HMS Corp executives and independent directors trade stock every 20 days with the average trade being worth of $938,779. The most recent stock trade was executed by Richard H Stowe on 19 October 2020, trading 3,530 units of HMSY stock currently worth $75,401.

What does HMS Corp do?

HMS advances healthcare by helping organizations reduce costs and improve health outcomes. Through its industry-leading technology, analytics and engagement solutions, HMS saves billions of dollars annually while helping consumers lead healthier lives. HMS provides a broad range of payment accuracy and population health management solutions that help move the healthcare system forward.

Complete history of Cynthia Nustad stock trades at HMS Corp

HMS Corp executives and stock owners

HMS Corp executives and other stock owners filed with the SEC include:

• William Lucia,
  Chairman of the Board, President, Chief Executive Officer
• Jeffrey Sherman,
  Chief Financial Officer, Executive Vice President, Treasurer
• Douglas Williams,
  Chief Operating Officer, Executive Vice President
• Emmet OGara,
  Group President, Population Health Management
• Meredith Bjorck,
  Executive Vice President, Corporate Secretary, Chief Legal Officer
• Cora Tellez,
  Lead Independent Director
• Richard Stowe,
  Independent Director
• Ellen Rudnick,
  Independent Director
• Craig Callen,
  Independent Director
• Bart Schwartz,
  Independent Director
• Robert Becker,
  Independent Director
• William Miller,
  Independent Director
• Jeffrey Rideout,
  Independent Director
• Katherine Baicker,
  Independent Director
• Robert Borchert,
  Senior Vice President, Investor Relations
• Jacob Sims,
  Senior Vice President, Chief Technology Officer
• Maria Perrin,
  Executive Vice President, Chief Growth Officer
• David Alexander,
  Chief Human Resource Officer, Senior Vice President, Chief Compliance Officer
• Greg D Aunan,
  SVP, Chief Accounting Officer
• Alex M Ii Azar,
  Director
• Teresa South,
  Chief Administrative Officer
• Robert M Holster,
  President
• Cynthia Nustad,
  CIO
• Emmet O'gara,
  Group Pres., Pop Health Mgmt.
• Semone Wagner,
  EVP, Operations
• Jzaneen Lalani,
  Chief Corporate Counsel
• Edith S Marshall,
  VP and General Counsel
• Walter D Hosp,
  SVP & CFO
• Andrea Benko,
  Executive Vice President
• Joel Portice,
  Division President
• Daniel Newman Mendelson,
  Director
• Ronald D Singh,
  EVP, Managed Care
• Spencer Young,
  President, HealthDataInsights
• Christina Dragonetti,
  
• William S Mosakowski,
  Director
• Joseph M Donabauer,
  
• Eugene V Defelice,
  EVP, General Counsel
• James Timothy Kelly,
  Director
• Michael A Stocker,
  Director
• Sean Curtin,
  
• John David Schmid,
  SVP
• William W Neal,
  Director
• Galen D Powers,
  Director
• Thomas G Archbold,
  Chief Financial Officer
• Philip Rydzewski,
  Chief Financial Officer
• Randolph G Brown,
  Director